Compounded Semaglutide vs Wegovy: Real Costs and Real Tradeoffs
Compounded semaglutide can still cost less upfront — one platform lists it starting at $60 plus a membership — but branded Wegovy self-pay is now $349 a month, or $199 for a new patient's first two fills. The gap has narrowed, and the compounded version skips FDA review entirely.
Semaglutides.org provides information only, not medical advice. Talk to a licensed provider about your own care before making changes. Some telehealth links are affiliate links and are labeled where they appear.
Compounded semaglutide can still be cheaper on paper, but the gap has narrowed a lot. One telehealth platform, Mochi Health, lists compounded semaglutide starting at $60 for the medication, but that price requires a separate Mochi Health membership, and the medication cost is not included in the membership fee [8]. Meanwhile, branded Wegovy injections now cost $349 a month for self-pay patients through NovoCare Pharmacy, and new patients pay $199 a month for their first two monthly fills of the two lowest doses, through December 31, 2026 [3]. Costco members can also get Ozempic or Wegovy injections for $349 for a 4-week supply at Costco Pharmacy, no insurance needed, according to Sesame’s announcement post about the partnership [4].
The honest comparison is all-in cost — medication plus any membership or visit fees — not the advertised medication price alone [8]. And price is only half the question. Compounded drugs are not reviewed by the FDA for safety, effectiveness or quality before they are marketed [1][2], which is the core of what you give up when you buy the compounded version.
A note on dates and prices: the NovoCare Pharmacy prices were verified September 15, 2026 on the NovoCare offer page [3], and the Mochi Health prices were verified September 15, 2026 on the Mochi pricing page [8]. The Costco and Sesame figures come from Sesame’s announcement post about the Costco partnership [4]. The Medicare, Medicaid and TrumpRx terms were announced November 6, 2025 [5][6], and the Zepbound vial prices were announced December 1, 2025 [7]. Telehealth and self-pay pricing changes frequently — reconfirm current figures directly with each provider before comparing.
What are compounded semaglutide and Wegovy, actually?
Semaglutide is the active ingredient in both Wegovy and Ozempic, which are made by Novo Nordisk [5]. Wegovy is an FDA-approved drug. Compounded semaglutide is a version mixed by a compounding pharmacy, and it is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed [1][2].
Under FDA policy, a compounded drug might be appropriate when a patient’s medical need cannot be met by an FDA-approved drug, or when the approved drug is not commercially available [2]. The FDA ended the semaglutide shortage on February 21, 2025, with deadlines affecting compounded supply [4].
There is also a physical difference. Compounded GLP-1s are often dispensed in multi-dose vials that the patient draws from with a syringe, rather than a prefilled pen [2]. The FDA recommends discarding a multi-dose vial within 28 days after first use, even if medication remains, and using a new sterile needle and syringe for every dose [2].
One more ingredient-level distinction: some compounders have sold salt forms of semaglutide — semaglutide sodium and semaglutide acetate. The FDA states these are different active ingredients than the ones in the approved drugs, and the agency is not aware of any lawful basis for their use in compounding [2].
How much does branded Wegovy cost without insurance now?
Through NovoCare Pharmacy, which is intended for patients without insurance or whose benefits do not cover the medicine, self-pay pricing is as follows (verified September 15, 2026 on the NovoCare offer page) [3]:
| Product | Dose | Self-pay price per month |
|---|---|---|
| Wegovy injection pen | 0.25, 0.5, 1, 1.7, or 2.4 mg | $349 |
| Wegovy HD injection pen | 7.2 mg | $399 |
| Wegovy tablets | 1.5 mg | $149 |
| Wegovy tablets | 4 mg | $199 |
| Wegovy tablets | 9 mg and 25 mg | $299 |
One month is defined as one box of 4 pens for the injection, or one bottle of 30 tablets for the pill [3]. A prescription is required [3].
New patients — those new to the Wegovy Savings Offer or NovoCare Pharmacy — pay $199 per month for the 0.25 mg and 0.5 mg doses, for two monthly fills, through December 31, 2026 [3]. Novo Nordisk reserves the right to modify or cancel the program at any time [3].
For reference, without any program, the list price of Wegovy is about $1,349 per month and Ozempic about $968 per month [4]. Existing obesity drugs generally run roughly $1,000 to $1,350 per month before insurance [5].
What about Costco, Sesame and TrumpRx?
Costco members can get Ozempic or Wegovy injections for $349 for a 4-week supply at Costco Pharmacy, self-pay, with an active prescription and no insurance needed, according to Sesame’s announcement post about the partnership [4]. New patients can get the two lowest doses for $199 per month for the first two months of treatment [4]. Costco partnered directly with Novo Nordisk for the flat self-pay price [4].
If you need a prescription, it can be obtained through the Success by Sesame online weight loss program if clinically appropriate [4]. A virtual primary care visit runs $29 for Costco members through Sesame [4]. Costco Executive Members and Costco Anywhere Visa cardholders get an extra 2% reward on the medication purchase [4].
Separately, on November 6, 2025, the White House announced deals with Novo Nordisk and Eli Lilly, with a consumer site, TrumpRx.gov, launching in January 2026 [5]. Under the announced terms, starting doses of existing injections like Wegovy and Zepbound would be $350 per month on TrumpRx, trending down to $245 per month over a two-year period [5]. Those are agreement terms with a stated two-year trend-down, not prices available today.
What will Medicare and Medicaid pay for GLP-1s?
Under the November 2025 agreements, Medicare and Medicaid will pay $245 per month for GLP-1s for weight loss and diabetes [5][6]. Medicare beneficiaries will have a copay of $50 per month for approved uses of injectable and oral GLP-1 drugs [5][6]. Starting doses of upcoming obesity pills from Eli Lilly and Novo Nordisk — pills still pending approval, not products on the market today — will be $149 per month for people getting them through Medicare, Medicaid or TrumpRx [5]. That $149 figure is not a price available today and does not describe currently marketed tablets.
Medicare’s new obesity coverage runs through a Part D pilot starting mid-2026, and about 10% of Medicare beneficiaries are expected to be eligible [5]. The eligibility cohorts are: BMI greater than 27 with prediabetes or established cardiovascular disease; BMI greater than 30 with uncontrolled hypertension, kidney disease or heart failure; and BMI greater than 35 [5]. Medicare covers about 66 million people [5].
State Medicaid programs must opt in to the $245 pricing, and some may not [5]. Wegovy and Zepbound have historically not been covered by Medicare for weight loss and only rarely by Medicaid [5].
How is compounded semaglutide priced, and what does it really cost?
Mochi Health lists compounded semaglutide starting at $60, plus a Mochi Health membership, and states plainly that the cost of medication is not included in the membership fee (verified September 15, 2026 on the Mochi pricing page) [8]. The price varies based on the dose a provider prescribes, with a dose ladder of 0.22, 0.44, 0.88, 1.5, 2.21, 2.67, 4.5 and 6.48 mg per week [8]. That means the advertised entry price reflects the starter dose only, and the price can rise as the prescribed dose changes [8].
Getting it requires a written prescription from a licensed provider, issued after a health questionnaire and a 30-minute video visit [8]. Mochi’s own page carries the disclaimer that compounded medications are not approved or evaluated by the FDA for safety, effectiveness or quality [8].
Other telehealth platforms structure pricing differently, and their current membership and medication prices change frequently — verify any platform’s all-in price directly on its own page before comparing.
What does an all-in monthly cost comparison look like?
| Route | Medication cost | Other required costs | Notes |
|---|---|---|---|
| Insured Wegovy with savings card | As little as $25/month | — | Savings capped at $100/month; government beneficiaries excluded [3] |
| Medicare pilot (starting mid-2026) | $50/month copay | — | About 10% of beneficiaries eligible [5] |
| Wegovy tablets, 1.5 mg, self-pay | $149/month | Any visit fee, e.g. $29 Sesame/Costco virtual visit | One bottle of 30 tablets [3][4] |
| Wegovy pen via NovoCare, self-pay | $349/month ($199 for first 2 fills if new) | — | Prescription required [3] |
| Ozempic or Wegovy injection via Costco | $349/month ($199 first 2 months if new) | Costco membership; visit fee if needed | No insurance needed [4] |
| Compounded semaglutide via Mochi | Starting at $60, dose-dependent | Separate Mochi membership fee | Not FDA-reviewed [8][1] |
| No program (list price reference) | ~$1,349/month Wegovy; ~$968/month Ozempic | — | Before insurance [4] |
Read the fine print on each row: the $25 insured figure is subject to a maximum savings of $100 per month and excludes government beneficiaries [3], and the compounded figure is a starting point that rises with dose plus a membership [8]. Each row reflects the provider page or announcement post cited in that row; the Medicare figures reflect the November 6, 2025 agreements [5][6].
Why is compounded semaglutide cheaper than Wegovy?
Compounded products skip the FDA’s premarket review for safety, effectiveness and quality [1][2]. They are typically sold in vial-and-syringe form rather than a prefilled pen [2]. Compounded GLP-1s may contain foreign-made active pharmaceutical ingredient that the FDA says may be manufactured without appropriate controls to assure quality, and the agency has established a green list import alert (66-80) to stop GLP-1 APIs with potential quality concerns from entering the US supply chain [2]. That import alert does not apply to API makers found compliant on FDA inspection, and it creates no new limits on legal compounding [2].
On the Mochi route, the medication is paid for out of pocket, priced separately from the membership fee [8].
What are you giving up beyond price?
The main thing is FDA review. Compounded drugs are not reviewed for safety, effectiveness or quality before marketing [1][2]. The FDA has also sent warning letters to telehealth firms for calling compounded drugs generic, the same as an FDA-approved drug, FDA-approved, or clinically proven to produce the same result [1]. The FDA does not approve or license any pharmacy or outsourcing facility, so claims of an “FDA-approved pharmacy” are misleading [1].
There is a documented safety record. As of May 31, 2026, the FDA had received 990 adverse event reports for compounded semaglutide and more than 730 for compounded tirzepatide [2]. Federal law does not require state-licensed pharmacies that are not outsourcing facilities to report adverse events to the FDA, so these are likely underreported [2].
Specific problems the FDA has identified include:
- Dosing errors with compounded injectable semaglutide — patients measuring wrong doses and, in some cases, clinicians miscalculating — with some adverse events requiring hospitalization [2].
- Reports of compounded doses exceeding the approved label: more product per dose, more frequent dosing or faster titration, with symptoms including nausea, vomiting, diarrhea, abdominal pain and constipation [2].
- Shipping failures, with compounded GLP-1s arriving warm or with inadequate ice packs; the FDA says not to use them [2].
- Fraudulent compounded semaglutide and tirzepatide with false label information, including nonexistent pharmacies and misused licensed pharmacy names [2].
- Counterfeit Ozempic found in the US drug supply chain [2].
The FDA also states that retatrutide and cagrilintide cannot lawfully be used in compounding, and have not been found safe and effective for any condition [2].
Does insurance ever cover compounded semaglutide?
The compounded route described here — Mochi — is paid for out of pocket, with the medication priced separately from the membership fee [8]. The branded savings-card route can reach as little as $25 per month, but it excludes government beneficiaries and caps savings at $100 per month [3]. Commercial plans will also receive discounts under the November 2025 agreements [6]. NovoCare Pharmacy’s self-pay path is designed for the uninsured or those whose coverage excludes the drug [3].
How does tirzepatide pricing compare?
Zepbound (tirzepatide) is a different molecule from semaglutide [5]. On December 1, 2025, Eli Lilly announced reduced Zepbound single-dose vial prices for self-pay patients via LillyDirect: the 2.5 mg vial is $299 per month (a $50 reduction), the 5 mg vial is $399 per month (a $100 reduction), and the 7.5, 10, 12.5 and 15 mg doses are $449 per month, down from $499 [7]. The Zepbound multidose pen is $299 per month at the lowest dose, up to $449 per month for higher doses [5]. Lilly’s oral drug, orforglipron, once approved, would start at $149 per month at the lowest dose [5].
Is compounded semaglutide going away?
The FDA declared the semaglutide shortage over on February 21, 2025, with deadlines affecting compounded supply [4]. The FDA has also warned active pharmaceutical ingredient distributors selling GLP-1 drugs to compounders, and outsourcing facilities repackaging retatrutide [2]. The agency says it remains vigilant over telehealth promotional materials and will keep taking action [1]. Compounding itself is not banned — the FDA’s import alert explicitly creates no new limits on legal compounding [2].
How do you compare two specific offers?
Work through this checklist with any two quotes in hand:
- Add the membership fee to the medication price. Mochi states the medication is not included in the membership [8].
- Ask whether the price rises with dose — compounded pricing varies by the prescribed weekly dose [8].
- Watch for the FDA’s red flags: claims that the compounded drug is the same as the approved drug, prices that seem too good to be true, no screening or prescription by a licensed doctor, no doctor available after delivery, and label spelling errors or a wrong pharmacy address [2].
- Ask which compounding pharmacy makes the product and verify it is state-licensed; the FDA’s BeSafeRx campaign is its resource for buying medicines online safely [2].
- Confirm whether a branded intro price applies only to new patients and only for two fills [3].
- Confirm whether a Costco membership and a separate visit fee are required on the retail route [4].
Telehealth and self-pay pricing changes frequently, and Novo Nordisk reserves the right to modify or cancel its programs at any time [3], so check current prices directly with each provider before deciding. Which drug, dose and form is appropriate is a decision for a licensed prescriber.
Sources
- US Food and Drug Administration. FDA to telehealth companies: what to know when promoting compounded drugs.
- US Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss.
- NovoCare Pharmacy. Wegovy (semaglutide) online pharmacy.
- Sesame. Costco members can now get half-priced Ozempic and Wegovy prescriptions through Sesame.
- CNBC. Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage. November 6, 2025.
- STAT. Trump announces deal with Lilly, Novo to expand access to weight loss drugs, cut prices. November 6, 2025.
- Pharmaceutical Executive. Lilly reduces price of Zepbound single-dose vials for self-pay patients. December 1, 2025.
- Mochi Health. Compounded semaglutide for weight loss.
- Ivim Health. GLP-1 pricing page.
- Ro. Get access to prescription weight loss medication online.
- GoodRx. Live updates: insurance coverage for GIP and GLP-1 agonists like Zepbound and Wegovy in 2026.
- GoodRx. Are compounded GLP-1s going away? Not entirely.
- knownwell. Medicare coverage for GLP-1 weight loss medications.
- US Food and Drug Administration. FDA proposes to exclude semaglutide, tirzepatide, and liraglutide on 503B bulks list.
- Fierce Pharma. Novo’s Wegovy pill makes US debut, with starter dose launching at $149 per month for cash-paying patients. January 5, 2026.
- LillyDirect. Telehealth for obesity.
- Novo Nordisk. Novo Nordisk announces significant reduction in US list price for Wegovy, Ozempic, and Rybelsus (semaglutide medicines), building on continued efforts to expand access.
- Centers for Medicare & Medicaid Services. Coming soon: CMS to provide $50 monthly access to GLP-1 medications for Medicare beneficiaries. May 6, 2026.
- Medical News Today. Type 2 diabetes: new Ozempic pill now available in the U.S.
Frequently asked questions
Is compounded semaglutide the same drug as Wegovy?
No. Both may contain semaglutide, but Wegovy is FDA-approved and reviewed for safety, effectiveness and quality, while compounded drugs are not reviewed by the FDA before marketing. Compounded versions are also often dispensed as multi-dose vials for self-administration rather than prefilled pens. Some compounders have even used salt forms that are different active ingredients from the approved drugs.
Why can't sellers call it generic Wegovy?
Generic drugs are approved by the FDA before marketing; compounded drugs are not. The FDA has issued warning letters to telehealth companies for describing compounded drugs as generic versions, the same as an FDA-approved drug, FDA-approved, or clinically proven to produce the same result. The FDA also does not approve or license any pharmacy or outsourcing facility, so "FDA-approved pharmacy" claims are misleading.
What is the cheapest way to get real Wegovy without insurance?
Wegovy tablets at 1.5 mg cost $149 per month self-pay through NovoCare Pharmacy, verified September 15, 2026. Wegovy injections are $349 per month, or $199 per month for a new patient's first two fills of the two lowest doses through December 31, 2026. Costco members can also get Wegovy or Ozempic injections for $349 for a 4-week supply, no insurance needed, per Sesame's announcement post.
Is the $199 Wegovy price permanent?
No. The $199 per month price applies only to patients new to the Wegovy Savings Offer or NovoCare Pharmacy, only for the 0.25 mg and 0.5 mg doses, and only for two monthly fills through December 31, 2026. After that, injections are $349 per month, or $399 for Wegovy HD 7.2 mg. Novo Nordisk also reserves the right to modify or cancel the program at any time.
Does insurance ever pay for compounded semaglutide?
The compounded route described here, Mochi, is paid for out of pocket, with the medication priced separately from its membership fee. Branded Wegovy with a savings card can reach as little as $25 per month, but savings are capped at $100 per month and government beneficiaries are excluded. Commercial plans will receive discounts under the November 2025 agreements.
What will Medicare pay for GLP-1 drugs?
Under the November 2025 agreements, Medicare will pay $245 per month for GLP-1s, with a $50 per month copay for beneficiaries on approved uses, including obesity coverage through a Part D pilot starting mid-2026. About 10% of Medicare beneficiaries are expected to qualify, based on BMI thresholds combined with conditions like prediabetes, cardiovascular disease or uncontrolled hypertension.
Is the Wegovy pill cheaper than compounded injections?
On medication price alone, it can be. Wegovy tablets cost $149 per month at 1.5 mg, $199 at 4 mg, and $299 at 9 mg and 25 mg, self-pay through NovoCare Pharmacy, verified September 15, 2026. Mochi's compounded semaglutide is listed starting at $60 plus a separate membership fee, and the price varies with the prescribed dose. The full comparison depends on dose, membership costs and which product a prescriber determines is appropriate.
How long can a compounded multi-dose vial be used after opening?
The FDA recommends discarding a multi-dose vial within 28 days after first use, even if medication remains, and even if the compounder's instructions say it can be used longer. Patients should also use a new, sterile needle and syringe for every dose, since reusing them can contaminate the medication.
This article summarizes FDA labeling, published research and company information current as of September 14, 2026. It is not medical advice and does not replace a conversation with your own healthcare provider. How we research and verify.